↓ Skip to main content

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

Overview of attention for article published in BMC Cancer, April 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report
Published in
BMC Cancer, April 2019
DOI 10.1186/s12885-019-5604-6
Pubmed ID
Authors

Marzia Del Re, Eleonora Rofi, Carla Cappelli, Gianfranco Puppo, Stefania Crucitta, Simona Valeggi, Antonio Chella, Romano Danesi, Iacopo Petrini

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 15%
Other 5 13%
Student > Bachelor 4 10%
Student > Doctoral Student 3 8%
Researcher 2 5%
Other 5 13%
Unknown 15 38%
Readers by discipline Count As %
Medicine and Dentistry 9 23%
Biochemistry, Genetics and Molecular Biology 7 18%
Neuroscience 2 5%
Agricultural and Biological Sciences 2 5%
Nursing and Health Professions 1 3%
Other 3 8%
Unknown 16 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2019.
All research outputs
#13,141,037
of 23,511,526 outputs
Outputs from BMC Cancer
#2,757
of 8,500 outputs
Outputs of similar age
#161,335
of 351,121 outputs
Outputs of similar age from BMC Cancer
#68
of 221 outputs
Altmetric has tracked 23,511,526 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,500 research outputs from this source. They receive a mean Attention Score of 4.4. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,121 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 221 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.